Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysisJournal of cancer research and clinical oncology, 2019-02, Vol.145 (2), p.479-485 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2018 ;Journal of Cancer Research and Clinical Oncology is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-018-2805-3 ;PMID: 30506406Full text available |
|
2 |
Material Type: Article
|
The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patientsJournal of cancer research and clinical oncology, 2020-01, Vol.146 (1), p.43-52 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;Journal of Cancer Research and Clinical Oncology is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-019-03079-8 ;PMID: 31705294Full text available |
|
3 |
Material Type: Article
|
Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learningJournal of cancer research and clinical oncology, 2021-03, Vol.147 (3), p.821-833 [Peer Reviewed Journal]The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-020-03366-9 ;PMID: 32852634Full text available |
|
4 |
Material Type: Article
|
Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patientsJournal of cancer research and clinical oncology, 2017-12, Vol.143 (12), p.2425-2435 [Peer Reviewed Journal]Springer-Verlag GmbH Germany 2017 ;Journal of Cancer Research and Clinical Oncology is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-017-2491-6 ;PMID: 28803328Full text available |
|
5 |
Material Type: Article
|
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignanciesJournal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.6181-6190 [Peer Reviewed Journal]The Author(s) 2023 ;2023. The Author(s). ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-022-04519-8 ;PMID: 36689060Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Primary lung cancer in children and adolescentsJournal of cancer research and clinical oncology, 2024-05, Vol.150 (5), p.225-225 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-024-05750-1 ;PMID: 38695944Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Imaging for local recurrence of breast cancerJournal of cancer research and clinical oncology, 2024-04, Vol.150 (4), p.200-200 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-024-05709-2 ;PMID: 38627285Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumorsJournal of cancer research and clinical oncology, 2023-07, Vol.149 (7), p.2833-2841 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 ;2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-022-04159-y ;PMID: 35788726Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Association of preoperative sarcopenia with the long-term prognosis of patients with bladder cancer undergoing radical cystectomyJournal of cancer research and clinical oncology, 2024-04, Vol.150 (4), p.173-173 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-024-05705-6 ;PMID: 38568255Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Development of a nomogram to predict the prognosis of patients with secondary bone tumors in the intensive care unit: a retrospective analysis based on the MIMIC IV databaseJournal of cancer research and clinical oncology, 2024-03, Vol.150 (3), p.164-164 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-024-05667-9 ;PMID: 38546896Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Using deep learning to predict survival outcome in non-surgical cervical cancer patients based on pathological imagesJournal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.6075-6083 [Peer Reviewed Journal]The Author(s) 2023 ;2023. The Author(s). ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-022-04446-8 ;PMID: 36653539Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinomaJournal of cancer research and clinical oncology, 2024-02, Vol.150 (2), p.81-81, Article 81 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;ISSN: 1432-1335 ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-023-05526-z ;PMID: 38319485Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from “Uncertain Significance” to “Pathogenic” based on minigene assays and clinical evidenceJournal of cancer research and clinical oncology, 2024-02, Vol.150 (2), p.62-62, Article 62 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;ISSN: 1432-1335 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-023-05597-y ;PMID: 38300310Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Ultrasound-based deep learning radiomics nomogram for risk stratification of testicular masses: a two-center studyJournal of cancer research and clinical oncology, 2024-01, Vol.150 (1), p.18-18, Article 18 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-023-05549-6 ;PMID: 38240867Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinomaJournal of cancer research and clinical oncology, 2023, Vol.149 (1), p.191-202 [Peer Reviewed Journal]The Author(s) 2023 ;2023. The Author(s). ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-022-04506-z ;PMID: 36595043Full text available |
|
16 |
Material Type: Article
|
Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancerJournal of cancer research and clinical oncology, 2023-12, Vol.149 (20), p.17987-17995 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-023-05490-8 ;PMID: 37975902Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinomaJournal of cancer research and clinical oncology, 2023-12, Vol.149 (19), p.17081-17091 [Peer Reviewed Journal]The Author(s) 2023 ;2023. The Author(s). ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-023-05424-4 ;PMID: 37750955Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Predicting cutaneous malignant melanoma patients’ survival using deep learning: a retrospective cohort studyJournal of cancer research and clinical oncology, 2023-12, Vol.149 (19), p.17103-17113 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-023-05421-7 ;PMID: 37755576Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapyJournal of cancer research and clinical oncology, 2022-11, Vol.148 (11), p.3103-3108 [Peer Reviewed Journal]The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-021-03878-y ;PMID: 35006344Full text available |
|
20 |
Material Type: Article
|
Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinomaJournal of cancer research and clinical oncology, 2023-07, Vol.149 (8), p.4163-4172 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;ISSN: 0171-5216 ;EISSN: 1432-1335 ;DOI: 10.1007/s00432-022-04323-4 ;PMID: 36050540Digital Resources/Online E-Resources |